Targeting anticancer drug-induced senescence in glioblastoma therapy

Oncotarget. 2018 Dec 25;9(101):37466-37467. doi: 10.18632/oncotarget.26502.

Authors

Maja T Tomicic^{1

2}, Markus Christmann^{1

2}

Affiliations

¹ Markus Christmann: Department of Toxicology, University Medical Center Mainz, Mainz, Germany.
² Maja T. Tomicic: Department of Toxicology, University Medical Center Mainz, Mainz, Germany.

No abstract available

Keywords: cancer; glioblastoma; senescence; senolytic drugs; temozolomide.

Publication types

Editorial